尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Peters Malte. Director active across 2 companies, notably Tango Therapeutics, Inc.. In total, 7 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €41k. Activity tracked since 6 June 2023. The latest transaction was filed on 8 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Peters Malte is an insider mentioned in 7 filings in total. Across the 7 sampled recent filings, the period runs from 2023-06-08 to 2026-01-12, with 0 EUR of buys and 40631 EUR of sells. The listed companies are Tango Therapeutics, Inc., where the role is President & CEO, and HOOKIPA Pharma Inc., where the role is Chief Executive Officer. The modal transaction nature is Attribution.